New mechanistic insights into modifiable risk factors that promote pancreatic cancer
New mechanistic insights into modifiable risk factors that promote pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.26813
Supriya Srinivasan,
Austin R. Dosch,
and Nagaraj S. Nagathihalli
|
| 2417-2418 |
Do tumor cells escape from natural killer cell cytotoxicity by mimicking dendritic cells?
Do tumor cells escape from natural killer cell cytotoxicity by mimicking dendritic cells? |
|
https://doi.org/10.18632/oncotarget.26815
Hannah Wurzer,
Antoun Al Absi,
Céline Hoffmann,
and Clément Thomas
|
| 2419-2420 |
BRCAness in prostate cancer
BRCAness in prostate cancer |
|
https://doi.org/10.18632/oncotarget.26818
Natalia Bednarz-Knoll,
Elke Eltze,
Axel Semjonow,
and Burkhard Brandt
|
| 2421-2422 |
Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin
Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin |
|
https://doi.org/10.18632/oncotarget.26814
Keita Kojima,
Naoko Minatani,
Hideki Ushiku,
Satoru Ishii,
Toshimichi Tanaka,
Keigo Yokoi,
Nobuyuki Nishizawa,
Yosuke Ooizumi,
Kazuharu Igarashi,
Kei Hosoda,
Hiromitsu Moriya,
Hiroaki Mieno,
Masahiko Watanabe,
and Keishi Yamashita
|
| 2423-2434 |
Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line
Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line |
|
https://doi.org/10.18632/oncotarget.26764
Kazuyoshi Yanagihara,
Takanori Kubo,
Yuki Iino,
Keichiro Mihara,
Chie Morimoto,
Toshio Seyama,
Takeshi Kuwata,
Atsushi Ochiai,
and Hiroshi Yokozaki
|
| 2435-2450 |
177Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer
177Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer |
|
https://doi.org/10.18632/oncotarget.26789
Finn Edler von Eyben,
Aviral Singh,
Jingjing Zhang,
Karin Nipsch,
Danielle Meyrick,
Nat Lenzo,
Kalevi Kairemo,
Timo Joensuu,
Irene Virgolini,
Cigdem Soydal,
Harshad R. Kulkarni,
and Richard Paul Baum
|
| 2451-2461 |
Sarcomas in the United States: Recent trends and a call for improved staging
Sarcomas in the United States: Recent trends and a call for improved staging |
|
https://doi.org/10.18632/oncotarget.26809
Michele M. Gage,
Neeraja Nagarajan,
Jessica M. Ruck,
Joseph K. Canner,
Salma Khan,
Katherine Giuliano,
Faiz Gani,
Christopher Wolfgang,
Fabian M. Johnston,
and Nita Ahuja
|
| 2462-2474 |
Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers |
|
https://doi.org/10.18632/oncotarget.26810
Tasnim Zaman,
Ping Sun,
Steven A. Narod,
Leonardo Salmena,
and Joanne Kotsopoulos
|
| 2475-2483 |
